Cargando…
Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
OBJECTIVES: The objectives of the study are to explore tolerability, acceptability and oncological outcomes for patients with high‐risk non‐muscle‐invasive bladder cancer (NMIBC) treated with hyperthermic intravesical chemotherapy (HIVEC) and mitomycin‐C (MMC) at our institution. PATIENTS AND METHOD...
Autores principales: | Conroy, Samantha, Pang, Karl, Jubber, Ibrahim, Hussain, Syed A., Rosario, Derek J., Cumberbatch, Marcus G., Catto, James W. F., Noon, Aidan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071075/ https://www.ncbi.nlm.nih.gov/pubmed/37025474 http://dx.doi.org/10.1002/bco2.203 |
Ejemplares similares
-
Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes
por: Reed, Oliver, et al.
Publicado: (2020) -
Epidemiology, aetiology and screening of bladder cancer
por: Cumberbatch, Marcus G. K., et al.
Publicado: (2019) -
Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
por: de Jong, Joep J., et al.
Publicado: (2018) -
A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
por: Van Hattum, J. W., et al.
Publicado: (2022) -
Outcomes and complications of Hyperthermic IntraVesical Chemotherapy using mitomycin C or epirubicin for patients with non-muscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure
por: Chiancone, Francesco, et al.
Publicado: (2020)